MOMELOTINIB (has an active metabolite) | MOMELOTINIB | ATC MOMELOTINIB
ANTINEOPLASTIC TREATMENT OF MYELOFIBROSIS JANUS KINASE 1 AND 2 (JAK1/JAK2) INHIBITOR AND AND MUTANT JAK2V617F | ORAL | Cmax 1.15 MICROMOLAR Tmax 2 HOUR VD 984 LITER PPB 91 PERCENT Cl 103 LITER / HOUR HT 6 HOUR SOLUBILITY SLIGHTLY SOLUBLE IN WATER | JANUS KINASE 1 AND 2 (JAK1/JAK2) PDB 8BXH (CRYSTAL STRUCTURE OF JAK2 JH1 IN COMPLEX WITH MOMELOTINIB) LIGAND CODE = C87 (link to the list of PDB complexes) Download experimental 3D coordinates of C87 with added hydrogens | - more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |